Engineered Cell Therapy | CHOP Research Institute

Optimizing Vector Delivery to Reduce Risk: Q&A With Beverly Davidson, PhD, and Misun Hwang, MD

Published on

Feb 6, 2023

Gene Therapy and Radiology Team Up to Optimize Vector Delivery

Two scientists with unique skill sets are developing an alternative method for gene therapy delivery with support from a CGTC Seed Grant.

Ma Laboratory for Immune Engineering

Our lab designs novel genetic, chemistry and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and leverages these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies.

Leyuan Ma, PhD

Dr. Ma focuses on immune engineering. He leverages genetic, chemistry, and engineering tools to dissect immune cell-cell and cell-tissue crosstalk and harness these crosstalk mechanisms to develop biomaterials, protein, and cell-based precision immunotherapies for cancer and autoimmune diseases.

E-mail:

mal5 [at] chop.edu

Cell and Gene Therapy Collaborative

The Cell and Gene Therapy Collaborative aims to significantly increase the number of potential new pediatric cell and gene therapies that are the product of CHOP-led research, and to accelerate the pace of clinical development in order to provide new therapies to children.